Long-term follow-up of MCL patients treated with single-agent ibrutinib: updated safety and efficacy results.
暂无分享,去创建一个
Michael L. Wang | R. Advani | W. Jędrzejczak | J. Radford | S. Stilgenbauer | K. Blum | Michael E. Williams | Liang Zhang | M. Dreyling | A. Goy | S. Rule | E. Chmielowska | W. Jurczak | J. Romaguera | S. Spurgeon | B. Kahl | D. Beaupre | M. Cheng | J. Barrientos | R. Auer | P. Martin | P. Johnson | L. Baher | Dana Lee | Peter W M Johnson | L. Zhang